May 21, 2026 05:02PM
May 18, 2026 08:02AM
May 15, 2026 07:35AM
May 6, 2026 08:58AM
Apr 30, 2026 06:25AM
Apr 30, 2026 04:35AM
Apr 29, 2026 03:23PM Teva Pharma (TEVA) PT Raised to $45 at Truist Securities
Apr 29, 2026 03:23PM
Apr 29, 2026 07:04AM
Apr 9, 2026 09:23AM
Apr 7, 2026 11:04AM
Mar 25, 2026 01:03AM
Mar 19, 2026 12:33PM
Mar 16, 2026 08:41AM Piper Sandler Reiterates Overweight Rating on Teva Pharma (TEVA)
Mar 9, 2026 10:53AM
Mar 6, 2026 11:00AM
Mar 4, 2026 07:42AM
Feb 20, 2026 03:38PM
Feb 20, 2026 02:43PM
Feb 20, 2026 04:00AM
Feb 19, 2026 04:00PM Corcept loses patent appeal against Teva over generic Korlym
Feb 19, 2026 11:05AM
Feb 19, 2026 10:34AM
Feb 13, 2026 10:38AM
Jan 28, 2026 05:05PM
Jan 28, 2026 03:54PM
Jan 28, 2026 07:08AM
Jan 27, 2026 11:18AM Teva Pharma (TEVA) call put ratio 3.4 calls to 1 put into quarter results
Jan 23, 2026 10:09AM
Jan 14, 2026 05:03PM
Jan 12, 2026 05:12AM
Jan 12, 2026 04:07AM
Jan 12, 2026 04:04AM
Jan 8, 2026 11:27AM
Jan 7, 2026 11:00AM Jefferies just introduced this pharma stock as a top 2026 idea
Dec 29, 2025 04:47AM
Dec 22, 2025 07:06AM
Dec 22, 2025 06:57AM
Dec 9, 2025 08:02AM
Dec 4, 2025 04:19PM
Nov 26, 2025 06:36AM
Nov 25, 2025 08:14AM Teva receives European approvals for two denosumab biosimilars
Nov 6, 2025 05:35AM
Nov 5, 2025 07:27AM
Oct 24, 2025 08:29AM
Oct 2, 2025 04:48AM
Sep 24, 2025 09:27AM
Sep 23, 2025 07:58AM
Sep 23, 2025 12:52AM Goldman Sachs Reiterates Buy Rating on Teva Pharma (TEVA)
Sep 17, 2025 08:01AM

413,396 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All